The funding announcement coincides with the launch of Cancer Research UK’s “Right Now” campaign, which aims to show both the realities of the disease and the positive impact research and improved treatments can have on people’s lives.
18th November 2019
As of the approval, the treatment is expected to be available to patients in the coming weeks.
18th November 2019
The trial is the first with an SGLT2 inhibitor investigating the treatment of heart failure in patients with reduced ejection fraction, with and without type II diabetes.
18th November 2019
The industry body hopes that the proceeding Government will “shape one of our country’s most valuable assets: an incredible pharmaceutical industry that employs tens of thousands and invests billions in research.”
18th November 2019
Isturisa, Mayzent and Polivy were among the recommendations.
18th November 2019
The study team will review how current health and social care systems work.
15th November 2019
The company has also submitted a marketing authorisation application for the drug to the European Medicines Agency.
15th November 2019
Last night the annual awards ceremony for the Marketer of the Year, Communications Team of the Year & Sales competitions took place at the gorgeous Chelsea Harbour Hotel.
15th November 2019
The therapy, a once-daily oral medicine, was initially approved in the US in May 2019 under the name Qternmet XR.
15th November 2019
The organisation updates its MS Guideline to state that Sativex should be offered to treat spasticity in people with the disorder.
14th November 2019
The study is the sixth Phase III trial of the drug’s programme.
14th November 2019
Only one drug has been approved for the indication in the lat 60 years, GlaxoSmithKline’s Benlysta (belimumab), which was also the first-ever biologic treatment for the disease.
14th November 2019
More than half of the public are not aware the condition may be preventable, and just under half are unaware of the steps that can be taken to prevent or delay the development of the condition.
14th November 2019
The impact of chronic hepatitis B treatment on hepatocellular carcinoma incidence was evaluated in a long-term analysis of the Gilead drug.
14th November 2019
Now celebrating its 10th anniversary, The Clinical Researcher of the Year – The Americas has opened its doors for entry.
14th November 2019
